These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29306403)

  • 1. Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood.
    Kuhn I; Rogosch T; Schindler TI; Tackenberg B; Zemlin M; Maier RF; Dodel R; Kronimus Y
    J Neuroimmunol; 2018 Feb; 315():33-39. PubMed ID: 29306403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
    Kronimus Y; Albus A; Balzer-Geldsetzer M; Straub S; Semler E; Otto M; Klotsche J; Dodel R; ; Mengel D
    PLoS One; 2016; 11(11):e0164953. PubMed ID: 27802290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson's Disease.
    Albus A; Kronimus Y; Burg-Roderfeld M; van der Wurp H; Willbold D; Ziehm T; Dodel R; Ross JA
    Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally occurring alpha-synuclein autoantibodies in Parkinson's disease: sources of (error) variance in biomarker assays.
    Heinzel S; Gold M; Deuschle C; Bernhard F; Maetzler W; Berg D; Dodel R
    PLoS One; 2014; 9(12):e114566. PubMed ID: 25470145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
    Besong-Agbo D; Wolf E; Jessen F; Oechsner M; Hametner E; Poewe W; Reindl M; Oertel WH; Noelker C; Bacher M; Dodel R
    Neurology; 2013 Jan; 80(2):169-75. PubMed ID: 23255825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.
    Albus A; Gold M; Bach JP; Burg-Roderfeld M; Jördens M; Kirchhein Y; Kronimus Y; Mengel D; Zerr I; Dodel R
    PLoS One; 2018; 13(8):e0202954. PubMed ID: 30157279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Serum Level α-Synuclein and Tau Protein in Autism Spectrum Disorder Compared to Controls.
    Kadak MT; Cetin I; Tarakçıoğlu MC; Özer ÖF; Kaçar S; Çimen B
    Neuropediatrics; 2015 Dec; 46(6):410-5. PubMed ID: 26479762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.
    Brudek T; Winge K; Folke J; Christensen S; Fog K; Pakkenberg B; Pedersen LØ
    Mol Neurodegener; 2017 Jun; 12(1):44. PubMed ID: 28592329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels.
    Horvath I; Iashchishyn IA; Forsgren L; Morozova-Roche LA
    ACS Chem Neurosci; 2017 Jun; 8(6):1170-1176. PubMed ID: 28263550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.
    Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R
    Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encoding the Sequence of Specific Autoantibodies Against beta-Amyloid and alpha-Synuclein in Neurodegenerative Diseases.
    Albus A; Jördens M; Möller M; Dodel R
    Front Immunol; 2019; 10():2033. PubMed ID: 31507618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.
    Maetzler W; Berg D; Synofzik M; Brockmann K; Godau J; Melms A; Gasser T; Hörnig S; Langkamp M
    J Alzheimers Dis; 2011; 26(1):171-9. PubMed ID: 21593566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against small heat-shock proteins in Alzheimer's disease as a part of natural human immune repertoire or activation of humoral response?
    Papuć E; Krupski W; Kurys-Denis E; Rejdak K
    J Neural Transm (Vienna); 2016 Apr; 123(4):455-61. PubMed ID: 26566902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT; Giasson BI; Kravitz AV; Golbe LI; Mark MH; Trojanowski JQ; Lee VM
    Exp Neurol; 2004 Jun; 187(2):279-88. PubMed ID: 15144854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
    Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
    Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
    Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
    Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
    Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depleting Trim28 in adult mice is well tolerated and reduces levels of α-synuclein and tau.
    Rousseaux MW; Revelli JP; Vázquez-Vélez GE; Kim JY; Craigen E; Gonzales K; Beckinghausen J; Zoghbi HY
    Elife; 2018 Jun; 7():. PubMed ID: 29863470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonism.
    Duka T; Rusnak M; Drolet RE; Duka V; Wersinger C; Goudreau JL; Sidhu A
    FASEB J; 2006 Nov; 20(13):2302-12. PubMed ID: 17077307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament.
    Bartos A; Fialová L; Svarcová J; Ripova D
    J Neuroimmunol; 2012 Nov; 252(1-2):100-5. PubMed ID: 22948089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.